theophylline has been researched along with Breathlessness in 74 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinical evidence obtained on efficacy of a new long-acting theophylline ventax in chronic obstructive bronchitis demonstrates that it has advantages over theophylline, produces positive changes in the patients' external respiration, dyspnea severity, auscultatory parameters, subjective response, is well tolerated and highly effective against chronic obstructive bronchitis." | 9.08 | [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis]. ( Evstratov, AI; Karpukhina, EP; Lapygina, MV; Nikitina, AV, 1997) |
| "This study sought answers to 2 questions: (1) Is severe dyspnea to the point of exhaustion regularly accompanied by diaphragmatic fatigue in patients with moderately severe chronic obstructive pulmonary disease (COPD)? (2) When diaphragmatic fatigue occurs in such patients, does theophylline prevent or delay its onset? Eight eucapnic patients with moderately severe COPD were subjected to 2 different stresses to the point of severe dyspnea requiring cessation of the stress." | 9.06 | Dyspnea and diaphragmatic fatigue in patients with chronic obstructive pulmonary disease. Responses to theophylline. ( Druz, WS; Kongragunta, VR; Sharp, JT, 1988) |
| "The effect of theophylline on NT-proBNP was prospectively evaluated by multiple regression analysis in 753 outpatients referred for pulmonary evaluation of dyspnea." | 7.76 | Theophylline and cardiac stress in patients with dyspnea: an observational study. ( Basler, B; Dreyhaupt, J; Wieshammer, S, 2010) |
| "Breathlessness is common in patients with chronic obstructive pulmonary disease (COPD) and often is the reason that the individual patient seeks medical attention." | 7.76 | The role of theophylline in the treatment of dyspnea in COPD. ( Mahler, DA, 1987) |
| "Dyspnea was rated using 2 clinical indexes based on 3 components affecting breathlessness: functional impairment, magnitude of task that evokes dyspnea, and the associated magnitude of effort." | 6.66 | Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. ( Loke, J; Mahler, DA; Matthay, RA; Snyder, PE; Wells, CK, 1985) |
| "Theophylline has been utilized widely as a bronchodilator, but only in recent years have its positive cardiovascular effects been recognized in patients with chronic obstructive pulmonary disease." | 6.37 | Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disease. ( Mahler, DA; Matthay, RA, 1986) |
| "In a 12-week, open-labeled, parallel-group randomized study, pulmonary functions and dyspnea scores were compared between the combination and theophylline alone therapy at baseline, and 4 and 8 weeks after randomization in COPD." | 5.13 | Effect of add-on therapy of tiotropium in COPD treated with theophylline. ( Aizawa, H; Hoshino, T; Ichiki, M; Iwanaga, T; Kawayama, T; Kinoshita, M; Koga, T; Takata, S; Tsuda, T, 2008) |
| "Our results indicate that adding theophylline to standard treatment with inhaled bronchodilators provides additional benefits in stable COPD patients by reducing dynamic pulmonary hyperinflation, improving exercise tolerance, dyspnea and QoL." | 5.11 | [Clinical and functional benefits of adding theophylline to a standard treatment with short acting bronchodilators in patients with COPD]. ( Borzone, G; Díaz, O; Dreyse, J; Lisboa, C; Silva, F, 2005) |
| "Clinical evidence obtained on efficacy of a new long-acting theophylline ventax in chronic obstructive bronchitis demonstrates that it has advantages over theophylline, produces positive changes in the patients' external respiration, dyspnea severity, auscultatory parameters, subjective response, is well tolerated and highly effective against chronic obstructive bronchitis." | 5.08 | [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis]. ( Evstratov, AI; Karpukhina, EP; Lapygina, MV; Nikitina, AV, 1997) |
| " Therefore, we examined the performance of the 6-min walk test, a rating of dyspnea following the walk test, and three different questionnaires measuring dyspnea in daily activities, in a controlled trial of inhaled salbutamol and oral theophylline in 24 patients with primary fixed chronic airflow limitation." | 5.07 | Measuring functional status in chronic lung disease: conclusions from a randomized control trial. ( Guyatt, GH; Keller, J; Nogradi, S; Singer, J; Townsend, M, 1991) |
| " The effect of theophylline and salbutamol, alone or combined, on pulmonary function and dyspnea during daily activities was examined." | 5.07 | Mechanism of bronchodilator effect in chronic airflow limitation. ( Guyatt, GH; Jaeschke, R; Keller, J; Newhouse, MT; Singer, J, 1991) |
| "This study sought answers to 2 questions: (1) Is severe dyspnea to the point of exhaustion regularly accompanied by diaphragmatic fatigue in patients with moderately severe chronic obstructive pulmonary disease (COPD)? (2) When diaphragmatic fatigue occurs in such patients, does theophylline prevent or delay its onset? Eight eucapnic patients with moderately severe COPD were subjected to 2 different stresses to the point of severe dyspnea requiring cessation of the stress." | 5.06 | Dyspnea and diaphragmatic fatigue in patients with chronic obstructive pulmonary disease. Responses to theophylline. ( Druz, WS; Kongragunta, VR; Sharp, JT, 1988) |
| " Although more controlled studies would be helpful, relatively clear-cut indications for the use of ventilatory stimulants exist for hypercapnic obesity-hypoventilation patients (medroxyprogesterone), myxedema (thyroid replacement), central apnea (acetazolamide), and periodic breathing in congestive heart failure (theophylline)." | 4.80 | Pharmacologic treatment of sleep-disordered breathing. ( Hudgel, DW; Thanakitcharu, S, 1998) |
| "The effect of theophylline on NT-proBNP was prospectively evaluated by multiple regression analysis in 753 outpatients referred for pulmonary evaluation of dyspnea." | 3.76 | Theophylline and cardiac stress in patients with dyspnea: an observational study. ( Basler, B; Dreyhaupt, J; Wieshammer, S, 2010) |
| "Breathlessness is common in patients with chronic obstructive pulmonary disease (COPD) and often is the reason that the individual patient seeks medical attention." | 3.76 | The role of theophylline in the treatment of dyspnea in COPD. ( Mahler, DA, 1987) |
| "In a hypothyroid patient who suffered also from chronic obstructive lung disease and mild congestive heart failure, treatment with 1 g/day theophylline administered orally, was followed by a life-threatening theophylline intoxication manifested by repeated epileptic fits and ventricular fibrillation, successfully reverted to sinus rhythm." | 3.66 | Life-threatening theophylline intoxication in a hypothyroid patient. ( Aderka, D; Garfinkel, D; Gitter, S; Pinkhas, J; Santo, M; Shavit, G, 1983) |
| "Tiotropium combined with low-dose theophylline significantly improved the symptoms and general health of patients with stable COPD of groups B and D after 6 months of follow-up." | 2.87 | Effects of Tiotropium Combined with Theophylline on Stable COPD Patients of Group B, D and its Impact on Small Airway Function: A Randomized Controlled Trial. ( Cheng, DY; Fan, LL; Wu, HX; Xiong, XF; Zhu, M, 2018) |
| "Bu-Fei Yi-Shen granule combined with acupoint sticking therapy showed beneficial effects for patients with stable COPD in the measured parameters over the 4-month treatment period and 6 months follow-up, with no relevant between-group differences in adverse events." | 2.77 | Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study. ( Bai, YP; Guo, LX; Li, JS; Li, SY; Li, ZG; Shao, SJ; Wang, MH; Wang, YF; Xie, Y; Yu, XQ; Zhang, NZ; Zhang, YJ; Zhu, L, 2012) |
| "The regression slope of breathlessness as a function of oxygen consumption (primary outcome), mean ratings of breathlessness throughout exercise and peak ratings of breathlessness were significantly higher with naloxone than normal saline." | 2.74 | Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. ( Baird, JC; Kraemer, WJ; Mahler, DA; Murray, JA; Ward, J; Waterman, LA; Zhang, X, 2009) |
| "Treatment of COPD patients with TP is more effective than with theophylline." | 2.73 | Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline. ( Aizawa, H; Gohara, R; Ichiki, M; Iwanaga, T; Kawayama, T; Kinoshita, M; Koga, H; Minami, S; Nishiyama, M; Sueyasu, Y, 2008) |
| "In total, 110 participants with COPD were randomly assigned to receive slow-release theophylline (100 mg b." | 2.72 | Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year. ( Liu, S; Qiu, R; Ran, P; Wang, X; Xie, J; Zeng, X; Zheng, J; Zhong, N; Zhou, Y, 2006) |
| "Theophylline therapy was continued in 20 patients and replaced by placebo from day 3 on in the remainder; measurements were repeated on days 5 and 6." | 2.67 | Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease. ( Jörres, RA; Kirsten, DK; Magnussen, H; Wegner, RE, 1993) |
| "When theophylline was withdrawn, all parameters were significantly worsened, but after reinstitution of treatment they all improved significantly." | 2.66 | Effects of withdrawal of sustained-release theophylline in patients with chronic obstructive lung disease. ( Aamodt, T; Dahle, R; Horgen, O, 1988) |
| "Dyspnea was rated using 2 clinical indexes based on 3 components affecting breathlessness: functional impairment, magnitude of task that evokes dyspnea, and the associated magnitude of effort." | 2.66 | Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. ( Loke, J; Mahler, DA; Matthay, RA; Snyder, PE; Wells, CK, 1985) |
| "Smoking cessation is the only known causative treatment option." | 2.43 | [Pharmacological treatment of COPD and future of anti-inflammatory therapy]. ( Bitter-Suermann, S; Kanniess, F; Magnussen, H; Watz, H, 2006) |
| "Theophylline has been utilized widely as a bronchodilator, but only in recent years have its positive cardiovascular effects been recognized in patients with chronic obstructive pulmonary disease." | 2.37 | Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disease. ( Mahler, DA; Matthay, RA, 1986) |
| "The pharmacological treatment of chronic obstructive pulmonary disease (COPD) can significantly improve quality of life by reducing exacerbations, dyspnea and exercise intolerance, thereby limiting the degree of handicap and improving daily activities." | 1.35 | [Pharmacological treatment of stable chronic obstructive pulmonary disease]. ( Allain, YM; Giraud, F; Huchon, G; Roche, N, 2009) |
| "We report on a patient with systemic lupus erythematosus who developed a shrinking lung syndrome." | 1.29 | The "shrinking lung syndrome" in SLE, treatment with theophylline. ( Breedveld, FC; Peeters, AJ; Sterk, PJ; Van Veen, S, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 42 (56.76) | 18.7374 |
| 1990's | 13 (17.57) | 18.2507 |
| 2000's | 14 (18.92) | 29.6817 |
| 2010's | 4 (5.41) | 24.3611 |
| 2020's | 1 (1.35) | 2.80 |
| Authors | Studies |
|---|---|
| Sanmartin-Fernandez, M | 1 |
| Zamorano, JL | 1 |
| Xiong, XF | 1 |
| Fan, LL | 1 |
| Wu, HX | 1 |
| Zhu, M | 1 |
| Cheng, DY | 1 |
| Allain, YM | 1 |
| Giraud, F | 1 |
| Huchon, G | 1 |
| Roche, N | 1 |
| Mahler, DA | 4 |
| Murray, JA | 1 |
| Waterman, LA | 1 |
| Ward, J | 1 |
| Kraemer, WJ | 1 |
| Zhang, X | 1 |
| Baird, JC | 1 |
| Stiefelhagen, P | 1 |
| Burki, NK | 1 |
| Lee, LY | 1 |
| Wieshammer, S | 1 |
| Dreyhaupt, J | 1 |
| Basler, B | 1 |
| Li, JS | 1 |
| Li, SY | 1 |
| Yu, XQ | 1 |
| Xie, Y | 1 |
| Wang, MH | 1 |
| Li, ZG | 1 |
| Zhang, NZ | 1 |
| Shao, SJ | 1 |
| Zhang, YJ | 1 |
| Zhu, L | 1 |
| Guo, LX | 1 |
| Bai, YP | 1 |
| Wang, YF | 1 |
| DOLLE, W | 1 |
| SAUDAN, Y | 1 |
| KONAR, NR | 1 |
| BAGCHI, DK | 1 |
| SAPOZNIK, HI | 1 |
| GOLICZ, LR | 1 |
| GUENTHNER, W | 1 |
| HEULIN, A | 1 |
| SORS, C | 1 |
| TAUB, SJ | 1 |
| GILBERT, J | 1 |
| ISRAUEL-ASSELAIN, R | 1 |
| Donohue, JF | 1 |
| Park, HW | 1 |
| Cho, JG | 1 |
| Yum, JH | 1 |
| Hong, YJ | 1 |
| Lim, JH | 1 |
| Kim, HG | 1 |
| Kim, JH | 1 |
| Ahn, YK | 1 |
| Jeong, MH | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
| Dreyse, J | 1 |
| Silva, F | 1 |
| Díaz, O | 1 |
| Borzone, G | 1 |
| Lisboa, C | 1 |
| Watz, H | 1 |
| Bitter-Suermann, S | 1 |
| Kanniess, F | 1 |
| Magnussen, H | 2 |
| Zhou, Y | 1 |
| Wang, X | 1 |
| Zeng, X | 1 |
| Qiu, R | 1 |
| Xie, J | 1 |
| Liu, S | 1 |
| Zheng, J | 1 |
| Zhong, N | 1 |
| Ran, P | 1 |
| Cazzola, M | 1 |
| Gabriella Matera, M | 1 |
| Minami, S | 1 |
| Kawayama, T | 2 |
| Ichiki, M | 2 |
| Nishiyama, M | 1 |
| Sueyasu, Y | 1 |
| Gohara, R | 1 |
| Kinoshita, M | 2 |
| Koga, H | 1 |
| Iwanaga, T | 2 |
| Aizawa, H | 2 |
| Kauser, F | 1 |
| LeGrand, SB | 1 |
| Hoshino, T | 1 |
| Tsuda, T | 1 |
| Takata, S | 1 |
| Koga, T | 1 |
| Smolensky, MH | 3 |
| Reinberg, A | 1 |
| Queng, JT | 1 |
| Branick, M | 1 |
| Beier, W | 1 |
| Lanser, K | 1 |
| Aderka, D | 1 |
| Shavit, G | 1 |
| Garfinkel, D | 1 |
| Santo, M | 1 |
| Gitter, S | 1 |
| Pinkhas, J | 1 |
| Nolte, D | 2 |
| Van Veen, S | 1 |
| Peeters, AJ | 1 |
| Sterk, PJ | 1 |
| Breedveld, FC | 1 |
| Entzian, P | 1 |
| Barth, J | 1 |
| Kirsten, DK | 1 |
| Wegner, RE | 1 |
| Jörres, RA | 1 |
| Vaz Fragoso, CA | 1 |
| Miller, MA | 1 |
| Nikitina, AV | 1 |
| Karpukhina, EP | 1 |
| Lapygina, MV | 1 |
| Evstratov, AI | 1 |
| Hudgel, DW | 1 |
| Thanakitcharu, S | 1 |
| Runo, JR | 1 |
| Ely, EW | 1 |
| Guyatt, GH | 3 |
| Townsend, M | 2 |
| Keller, J | 2 |
| Singer, J | 2 |
| Nogradi, S | 2 |
| Fourrier, E | 1 |
| Sweer, L | 1 |
| Zwillich, CW | 1 |
| Jaeschke, R | 1 |
| Newhouse, MT | 2 |
| Cogo, R | 1 |
| Monzani, GP | 1 |
| Fusillo, M | 1 |
| Vota, M | 1 |
| Taurand, P | 1 |
| Murciano, D | 1 |
| Auclair, MH | 1 |
| Pariente, R | 1 |
| Aubier, M | 1 |
| Giosuè, S | 1 |
| Parola, D | 1 |
| Cafaggi, R | 1 |
| Astengo, D | 1 |
| Greco, G | 1 |
| D'Onofrio, V | 1 |
| Pugsley, SO | 1 |
| Keller, JL | 1 |
| Aamodt, T | 1 |
| Dahle, R | 1 |
| Horgen, O | 1 |
| D'Alonzo, GE | 1 |
| Kunkel, G | 1 |
| Barnes, PJ | 1 |
| Kongragunta, VR | 1 |
| Druz, WS | 1 |
| Sharp, JT | 1 |
| Cohen, BM | 1 |
| Manresa, F | 1 |
| Matthay, RA | 2 |
| Snyder, PE | 1 |
| Wells, CK | 1 |
| Loke, J | 1 |
| Gilbert, R | 1 |
| Fréour, P | 1 |
| Bernadou, M | 1 |
| Chomy, P | 1 |
| Rubin, AE | 1 |
| Bruderman, I | 1 |
| Etter, RL | 1 |
| Jackson, RH | 1 |
| Raymer, WJ | 1 |
| Günthner, W | 1 |
| Haslreiter, E | 1 |
| Krieger, E | 1 |
| John, P | 1 |
| Van Schepdael, J | 1 |
| Solvay, H | 1 |
| Hammer, O | 1 |
| Fourcaud, G | 1 |
| Begassat, F | 1 |
| Blamoutier, J | 1 |
| Mot, JC | 1 |
| Travagli, JP | 1 |
| Queneau, P | 1 |
| Le Guyader, J | 1 |
| Pont, M | 1 |
| Fruhmann, G | 1 |
| de Lostalot, J | 1 |
| Despierres, G | 1 |
| Cotte, J | 1 |
| Quinton, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease[NCT00458419] | 17 participants (Actual) | Interventional | 2005-09-30 | Completed | |||
| Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD[NCT03984188] | Phase 3 | 100 participants (Actual) | Interventional | 2021-02-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for theophylline and Breathlessness
| Article | Year |
|---|---|
Therapeutic responses in asthma and COPD. Bronchodilators.
Topics: Adrenergic beta-Agonists; Asthma; Bronchodilator Agents; Cholinergic Antagonists; Dyspnea; Forced Ex | 2004 |
[Pharmacological treatment of COPD and future of anti-inflammatory therapy].
Topics: Acetylcysteine; Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti- | 2006 |
The chronobiology and chronopharmacology of allergy.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Asthma; Biological Clocks; Bronchodilator Agen | 1981 |
Review of the clinical efficacy of theophylline in the treatment of chronic obstructive pulmonary disease.
Topics: Animals; Cardiovascular System; Dyspnea; Humans; Lung Diseases, Obstructive; Mucous Membrane; Muscle | 1993 |
Pharmacologic treatment of sleep-disordered breathing.
Topics: Acetazolamide; Antihypertensive Agents; Apnea; Bronchodilator Agents; Diuretics; Dyspnea; Evidence-B | 1998 |
Treating dyspnea in a patient with advanced chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Anti-Anxiety Agents; Breathing Exercises; Bronchodilator Agents; D | 2001 |
[Day-night pattern of bronchial width and dyspnea: basis for selection of optimal dosage schedules for theophylline].
Topics: Asthma; Bronchi; Circadian Rhythm; Drug Administration Schedule; Dyspnea; Humans; Theophylline | 1991 |
[Current concepts of asthma in children].
Topics: Adrenal Cortex Hormones; Asthma; Child; Child, Preschool; Combined Modality Therapy; Diagnosis, Diff | 1990 |
Dyspnea in the patient with chronic obstructive pulmonary disease. Etiology and management.
Topics: Anti-Anxiety Agents; Breathing Exercises; Bronchodilator Agents; Dyspnea; Humans; Lung Diseases, Obs | 1990 |
The role of theophylline in the treatment of dyspnea in COPD.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Dyspnea; Exercise Test; Forced Expirator | 1987 |
Day-night patterns in bronchial patency and dyspnea: basis for once-daily and unequally divided twice-daily theophylline dosing schedules.
Topics: Asthma; Bronchi; Circadian Rhythm; Drug Administration Schedule; Dyspnea; Humans; Theophylline | 1987 |
Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disease.
Topics: Dyspnea; Heart; Hemodynamics; Humans; Lung Diseases, Obstructive; Myocardial Contraction; Theophylli | 1986 |
22 trials available for theophylline and Breathlessness
| Article | Year |
|---|---|
Effects of Tiotropium Combined with Theophylline on Stable COPD Patients of Group B, D and its Impact on Small Airway Function: A Randomized Controlled Trial.
Topics: Aged; Bronchodilator Agents; Drug Therapy, Combination; Dyspnea; Female; Humans; Male; Middle Aged; | 2018 |
Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; beta-Endorphin; Bronchodilator Agents; | 2009 |
Blockade of airway sensory nerves and dyspnea in humans.
Topics: Adolescent; Adult; Anesthetics, Local; Double-Blind Method; Dyspnea; Female; Humans; Lidocaine; Male | 2010 |
Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.
Topics: Acupuncture Points; Acupuncture Therapy; Administration, Oral; Aged; Bronchodilator Agents; China; C | 2012 |
[Clinical and functional benefits of adding theophylline to a standard treatment with short acting bronchodilators in patients with COPD].
Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Bronchodilator Agents; Double-Bli | 2005 |
Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
Topics: Aged; Bronchodilator Agents; Double-Blind Method; Dyspnea; Female; Forced Expiratory Volume; Humans; | 2006 |
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study.
Topics: Aged; Albuterol; Bronchodilator Agents; Drug Administration Schedule; Drug Interactions; Drug Therap | 2007 |
Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline.
Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Aged, 80 and over; Bronchodilator Agent | 2008 |
Effect of add-on therapy of tiotropium in COPD treated with theophylline.
Topics: Aged; Bronchodilator Agents; Drug Therapy, Combination; Dyspnea; Female; Follow-Up Studies; Forced E | 2008 |
[Oral theophylline therapy for dyspnea].
Topics: Administration, Oral; Aged; Biological Availability; Dyspnea; Emergencies; Female; Half-Life; Humans | 1984 |
Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease.
Topics: Aged; Double-Blind Method; Dyspnea; Exercise Tolerance; Female; Humans; Lung Diseases, Obstructive; | 1993 |
[Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis].
Topics: Adult; Aged; Bronchitis; Bronchodilator Agents; Chronic Disease; Dyspnea; Female; Follow-Up Studies; | 1997 |
Measuring functional status in chronic lung disease: conclusions from a randomized control trial.
Topics: Aged; Albuterol; Chronic Disease; Double-Blind Method; Dyspnea; Exercise Test; Female; Humans; Lung; | 1991 |
Mechanism of bronchodilator effect in chronic airflow limitation.
Topics: Activities of Daily Living; Aged; Albuterol; Drug Therapy, Combination; Dyspnea; Forced Expiratory V | 1991 |
A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
Topics: Bronchitis; Carbon Dioxide; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Meth | 1989 |
Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation.
Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Analysis of Variance; Clinical Tr | 1988 |
Effects of withdrawal of sustained-release theophylline in patients with chronic obstructive lung disease.
Topics: Adult; Aged; Delayed-Action Preparations; Double-Blind Method; Drug Tolerance; Dyspnea; Female; Forc | 1988 |
The role of theophylline in the treatment of dyspnea in COPD.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Dyspnea; Exercise Test; Forced Expirator | 1987 |
Dyspnea and diaphragmatic fatigue in patients with chronic obstructive pulmonary disease. Responses to theophylline.
Topics: Diaphragm; Dyspnea; Electromyography; Exercise Test; Humans; Lung Diseases, Obstructive; Muscles; Re | 1988 |
Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease.
Topics: Administration, Oral; Double-Blind Method; Dyspnea; Humans; Lung Diseases, Obstructive; Male; Middle | 1985 |
Effects of theophylline-alcohol with potassium iodide in asthmatic patients.
Topics: Adult; Asthma; Clinical Trials as Topic; Cough; Dyspnea; Female; Humans; Male; Potassium Iodide; Res | 1969 |
[Clinical-experimental trial of a bisolvon-ephedrine-theophylline-combination preparation for treatment of asthmatic dyspnea].
Topics: Adult; Aged; Asthma; Clinical Trials as Topic; Dyspnea; Ephedrine; Expectorants; Female; Humans; Mal | 1968 |
41 other studies available for theophylline and Breathlessness
| Article | Year |
|---|---|
Theophylline for Attenuating Ticagrelor-Related Dyspnea.
Topics: Dyspnea; Humans; Platelet Aggregation Inhibitors; Theophylline; Ticagrelor | 2021 |
[Pharmacological treatment of stable chronic obstructive pulmonary disease].
Topics: Bronchodilator Agents; Drug Tolerance; Dyspnea; Exercise Test; Exercise Tolerance; Forced Expiratory | 2009 |
[Pulmonary diseases in pregnancy. What drugs are permitted?].
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antitubercular Agents; | 2009 |
Theophylline and cardiac stress in patients with dyspnea: an observational study.
Topics: Adult; Age Factors; Aged; Airway Obstruction; Bronchodilator Agents; Dyspnea; Female; Heart Diseases | 2010 |
[New soluble derivative of theophylline combined with phenobarbital].
Topics: Asthma; Barbiturates; Dyspnea; Dyspnea, Paroxysmal; Phenobarbital; Theophylline | 1952 |
[Clinical experience with hydroxyethyltheophyllin].
Topics: Coronary Disease; Dyspnea; Dyspnea, Paroxysmal; Theophylline | 1954 |
[Treatment of asthmatic dyspnea with neo-efrodal].
Topics: Asthma; Dyspnea; Theophylline | 1956 |
Choline theophyllinate in the relief of dyspnoea.
Topics: Choline; Dyspnea; Humans; Theophylline | 1958 |
Choledyl, choline theophyllinate (BAN).
Topics: Asthma; Dyspnea; Dyspnea, Paroxysmal; Humans; Theophylline | 1959 |
Clinical experience with Elixophyllin in dyspnea.
Topics: Asthma; Dyspnea; Dyspnea, Paroxysmal; Humans; Pulmonary Emphysema; Theophylline | 1960 |
The use of an oral preparation of theophylline for long and short term therapy.
Topics: Bronchi; Bronchial Diseases; Disease; Dyspnea; Humans; Theophylline | 1961 |
[SPIROGRAPHIC STUDIES ON ASTHMATIC DYSPNEA].
Topics: Asthma; Atropine; Dyspnea; Humans; Papaverine; Phenobarbital; Spirometry; Theophylline | 1963 |
[CLINICAL STUDY OF A EUPNEIC AGENT: AMPLIPHYLLINE].
Topics: Asthma; Bronchiectasis; Bronchitis; Bronchodilator Agents; Dyspnea; Dyspnea, Paroxysmal; Humans; Lun | 1964 |
THE DIAGNOSIS AND TREATMENT OF ASTHMA IN THE ELDERLY.
Topics: Aerosols; Aged; Asthma; Betamethasone; Bronchiectasis; Bronchitis; Dexamethasone; Dyspnea; Dyspnea, | 1964 |
[TREATMENT AND PREVENTION OF CHRONIC DYSPNEIC BRONCHITIS].
Topics: Adrenocorticotropic Hormone; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitussive Agents; | 1964 |
Clinical characteristics of hypervagotonic sinus node dysfunction.
Topics: Dizziness; Dyspnea; Female; Humans; Male; Middle Aged; Muscle Weakness; Sick Sinus Syndrome; Syncope | 2004 |
Theophylline for unexplained dyspnea in palliative medicine: a case report.
Topics: Aged; Bronchodilator Agents; Dyspnea; Humans; Male; Palliative Care; Prostatic Neoplasms; Theophylli | 2008 |
Life-threatening theophylline intoxication in a hypothyroid patient.
Topics: Aged; Dyspnea; Half-Life; Heart Failure; Humans; Hypothyroidism; Lung Diseases, Obstructive; Male; T | 1983 |
[Dyspnea--what is to be done?].
Topics: Diazepam; Digoxin; Diuretics; Dyspnea; Emergencies; Epinephrine; Glucocorticoids; Humans; Lidocaine; | 1982 |
The "shrinking lung syndrome" in SLE, treatment with theophylline.
Topics: Dyspnea; Female; Humans; Lung Diseases; Lupus Erythematosus, Systemic; Middle Aged; Theophylline | 1993 |
[Diagnostic errors in dyspnea].
Topics: Adenocarcinoma, Mucinous; Adult; alpha 1-Antitrypsin Deficiency; Diagnostic Errors; Dyspnea; Heart F | 1993 |
[When cowboys are short of air. Alarm signs overlooked].
Topics: Adrenergic beta-Agonists; Cholinergic Antagonists; Dyspnea; Humans; Pulmonary Disease, Chronic Obstr | 2001 |
[Acute dyspnea].
Topics: Adrenal Cortex Hormones; Airway Obstruction; Anti-Arrhythmia Agents; Asthma; Diagnosis, Differential | 1978 |
[Therapeutic effectiveness of bamifylline in elderly patients with COPD].
Topics: Aged; Bronchodilator Agents; Dyspnea; Female; Humans; Lung Diseases, Obstructive; Male; Respiratory | 1991 |
[Wheezing dyspnea].
Topics: Albuterol; Child; Dyspnea; Humans; Male; Respiratory Sounds; Theophylline | 1990 |
[The grade of dyspnea in patients treated with a theophylline derivative (bamifylline) vs controlled-absorption theophylline].
Topics: Bronchodilator Agents; Dyspnea; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Physi | 1987 |
Does theophylline improve dyspnea in nonreversible COPD?
Topics: Adult; Aged; Dyspnea; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Theophylline | 1986 |
Should symptoms--namely cough and dyspnoea--be treated?
Topics: Codeine; Cough; Diazepam; Dyspnea; Ethanol; Humans; Oxygen Inhalation Therapy; Promethazine; Theophy | 1986 |
Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease.
Topics: Delayed-Action Preparations; Dyspnea; Humans; Physical Exertion; Theophylline | 1985 |
[A dimefline-theophylline association in the treatment of dyspnea due to bronchial spasm].
Topics: Adolescent; Adult; Asthma; Bronchial Neoplasms; Bronchial Spasm; Child; Drug Combinations; Dyspnea; | 1972 |
Overdistension of lung due to peripheral airways obstruction.
Topics: Adolescent; Airway Obstruction; Ampicillin; Body Temperature; Dyspnea; Female; Humans; Lung; Lung Co | 1973 |
[Treatment of decompensated cor pulmonale with heptaminol theophyllineacetate].
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure Determination; Cardiac Glyco | 1972 |
[Clinical trial of diniprophylline-phenobarbital (Corverum) in oppressive cardio-respiratory disorders].
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Child; Drug Combinations; Dyspnea; Female; Humans; | 1972 |
[Therapy of asthmatic dyspnea].
Topics: Asthma; Barbiturates; Drug Synergism; Dyspnea; Glucocorticoids; Humans; Papaverine; Theophylline | 1969 |
[Experimentation with diniprofylline in geriatrics].
Topics: Adult; Aged; Dyspnea; Humans; Middle Aged; Nicotinic Acids; Pulmonary Heart Disease; Respiratory Ins | 1970 |
[Advantage of a new therapeutic agent for respiratory dyspneic diseases].
Topics: Asthma; Bronchial Diseases; Bronchodilator Agents; Caffeine; Dyspnea; Male; Parasympatholytics; Theo | 1970 |
[Clinical study of heptaminol acefyllinate].
Topics: Aged; Amino Alcohols; Dyspnea; Female; Heart Diseases; Humans; Liver Cirrhosis; Male; Middle Aged; N | 1967 |
[Clinical aspects and therapy of disturbed intrapulmonary respiratory mechanism].
Topics: Adrenal Cortex Hormones; Adult; Aged; Dyspnea; Epinephrine; Female; Humans; Lung; Respiratory Insuff | 1967 |
[A bronchodilator and spasmolytic of a new formula: AC 3810 (trentadil). Clinical trial and comparison with theophylline].
Topics: Aged; Asthma; Bronchial Diseases; Bronchodilator Agents; Dyspnea; Dyspnea, Paroxysmal; Humans; Lung | 1967 |
[Eupneizing and pyridoxine-like action of a new synthetic compound: Pyridofylline].
Topics: Adult; Aged; Dyspnea; Humans; Middle Aged; Pyridoxine; Theophylline | 1966 |
[Therapeutic actions of Pyridofylline in dyspnea, hyperlipemia and certain hepatobiliary diseases].
Topics: Adult; Biliary Tract Diseases; Dyspnea; Female; Humans; Hyperlipidemias; Liver Diseases; Male; Pyrid | 1966 |